Swiss Advanced Vision announces new clinical evidence confirming the exceptional performance of its Lucidis® intraocular lens ...

The FineVision trifocal diffractive IOL has three focal points for far, near and intermediate vision. This study examines the outcome of bilateral implantation of this IOL and provides far, ...

Please provide your email address to receive an email when new articles are posted on . Twelve years ago at the AECOS meeting, a program chair asked the audience if in 10 years we would be able to ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity ® Registry Study, which monitored ...

Please provide your email address to receive an email when new articles are posted on . The first FDA-approved presbyopia-correcting IOL entered the U.S. market in 1997 when the Allergan Medical ...

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (BLCO:CA), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark approval for ...

BENGALURU, India--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon ® Family of intraocular ...

Here is the current list (as of Feb. 9, 2011) of posterior chamber (P-C) and anterior chamber (A-C) intraocular lenses recognized by CMS. – Crystalens, manufactured by Eyeonics (now Bausch & Lomb). – ...

Swiss Advanced Vision announces new clinical evidence confirming the exceptional performance of its Lucidis intraocular lens (IOL), strengthening its position as a disruptive solution in premium catar ...